[LCID Study Number: 2018-006]
Esmolol to treat the hemodynamic effects of septic shock
The primary objective of this study is to determine if continuous infusion of esmolol improves the hemodynamic profile in septic shock by decreasing the need for vasopressor support.
Primary Contact Email: [email protected]
Primary Contact Phone: 781-744-2940